Sentiment-Signal
18,6
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
7.3
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 10.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ¨ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 29.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ay differ materially from these estimates. Item 5.02 Departure of Directors or Certain Officers; Election of Directors |
| 05.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 12.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 20.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 22.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 11.04.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
Stammdaten
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
Unternehmen & Branche
| Name | IRONWOOD PHARMACEUTICALS INC |
|---|---|
| Ticker | IRWD |
| CIK | 0001446847 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 46333X108 |
|---|---|
| ISIN | US46333X1081 |
| Typ | Common Stock |
| Marktkapitalisierung | 718,3 Mio. USD |
| Beta | 0,17 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 47,709,000 | -2,276,000 | -0.01 | 396,901,000 | -261,835,000 |
| 2025-09-30 | 10-K | 122,060,000 | 40,080,000 | 0.23 | ||
| 2025-09-30 | 10-Q | 122,060,000 | 40,080,000 | 0.23 | 396,062,000 | -264,157,000 |
| 2025-06-30 | 10-K | 85,239,000 | 23,599,000 | 0.14 | ||
| 2025-06-30 | 10-Q | 85,239,000 | 23,599,000 | 0.14 | 342,946,000 | -308,162,000 |
| 2025-03-31 | 10-K | 41,143,000 | -37,386,000 | -0.23 | ||
| 2025-03-31 | 10-Q | 41,143,000 | -37,386,000 | -0.23 | 327,213,000 | -334,053,000 |
| 2024-12-31 | 10-K | 90,545,000 | 2,256,000 | 0.01 | 350,908,000 | -301,335,000 |
| 2024-09-30 | 10-K | 91,592,000 | 3,646,000 | 0.02 | ||
| 2024-09-30 | 10-Q | 91,592,000 | 3,646,000 | 0.02 | 389,519,000 | -311,334,000 |
| 2024-06-30 | 10-Q | 94,396,000 | -860,000 | -0.01 | 395,620,000 | -321,727,000 |
| 2024-06-30 | 10-K | 94,396,000 | -860,000 | -0.01 | ||
| 2024-03-31 | 10-Q | 74,877,000 | -4,162,000 | -0.03 | 438,819,000 | -330,518,000 |
| 2024-03-31 | 10-K | 74,877,000 | -4,162,000 | -0.03 | ||
| 2023-12-31 | 10-K | 117,553,000 | -1,087,000 | -0.01 | 471,073,000 | -346,295,000 |
| 2023-09-30 | 10-K | 113,739,000 | 15,321,000 | 0.09 | ||
| 2023-09-30 | 10-Q | 113,739,000 | 15,321,000 | 0.09 | 524,063,000 | -323,216,000 |
| 2023-06-30 | 10-Q | 107,382,000 | -1,062,187,000 | -6.84 | 603,220,000 | -345,704,000 |
| 2023-06-30 | 10-K | 107,382,000 | -1,062,187,000 | -6.84 | ||
| 2023-03-31 | 10-Q | 104,061,000 | 45,714,000 | 0.25 | 1,155,277,000 | 706,852,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 15,958,196 | 0 | 15,958,196 | 53,779,120 | Neu | +100,0% | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 46,942,000 | 0 | 46,942,000 | 44,735,726 | Neu | +100,0% | |
| BlackRock, Inc. | 12,784,806 | 0 | 12,784,806 | 43,084,796 | Neu | +100,0% | |
| Context Capital Management, LLC | 42,119,000 | 0 | 42,119,000 | 39,802,455 | Neu | +100,0% | |
| UBS Group AG | 11,710,863 | 0 | 11,710,863 | 39,465,609 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 11,521,660 | 0 | 11,521,660 | 38,827,995 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 8,204,973 | 0 | 8,204,973 | 27,650,759 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4,975,939 | 0 | 4,975,939 | 16,768,914 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 4,723,531 | 0 | 4,723,531 | 15,918,299 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 4,424,002 | 0 | 4,424,002 | 14,908,888 | Neu | +100,0% | |
| STATE STREET CORP | 4,411,222 | 0 | 4,411,222 | 14,865,818 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3,623,534 | 0 | 3,623,534 | 12,213,817 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 11,767,446 | 0 | 11,767,446 | 11,422,518 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 2,853,205 | 0 | 2,853,205 | 9,615,301 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 2,836,462 | 0 | 2,836,462 | 9,558,877 | Neu | +100,0% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,759,667 | 0 | 2,759,667 | 9,300,078 | Neu | +100,0% | |
| Connor, Clark & Lunn Investment Management Ltd. | 1,990,927 | 0 | 1,990,927 | 6,709,424 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 1,681,229 | 0 | 1,681,229 | 5,665,742 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,275,315 | 0 | 1,275,315 | 4,297,812 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1,233,685 | 0 | 1,233,685 | 4,157,518 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 1,109,924 | 0 | 1,109,924 | 3,740,444 | Neu | +100,0% | |
| LAZARD ASSET MANAGEMENT LLC | 1,000,445 | 0 | 1,000,445 | 3,371,500 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 869,826 | 0 | 869,826 | 2,931,314 | Neu | +100,0% | |
| ADVENT CAPITAL MANAGEMENT /DE/ | 3,000,000 | 0 | 3,000,000 | 2,837,126 | Neu | +100,0% | |
| MORGAN STANLEY | 739,685 | 0 | 739,685 | 2,492,739 | Neu | +100,0% | |
| FMR LLC | 686,737 | 0 | 686,737 | 2,314,305 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 673,862 | 0 | 673,862 | 2,270,914 | Neu | +100,0% | |
| IEQ CAPITAL, LLC | 633,260 | 0 | 633,260 | 2,134,086 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 560,713 | 0 | 560,713 | 1,889,603 | Neu | +100,0% | |
| Walleye Capital LLC | 527,936 | 0 | 527,936 | 1,779,144 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 515,299 | 0 | 515,299 | 1,736,557 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 503,942 | 0 | 503,942 | 1,698,284 | Neu | +100,0% | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 495,993 | 0 | 495,993 | 1,671,496 | Neu | +100,0% | |
| Invesco Ltd. | 449,219 | 0 | 449,219 | 1,513,867 | Neu | +100,0% | |
| Range Financial Group LLC | 426,095 | 0 | 426,095 | 1,435,940 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 412,061 | 0 | 412,061 | 1,388,646 | Neu | +100,0% | |
| BARCLAYS PLC | 392,904 | 0 | 392,904 | 1,324,086 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 385,583 | 0 | 385,583 | 1,299,415 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 371,769 | 0 | 371,769 | 1,252,861 | Neu | +100,0% | |
| Robeco Institutional Asset Management B.V. | 342,998 | 0 | 342,998 | 1,155,903 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 330,836 | 0 | 330,836 | 1,114,917 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 515,607 | 0 | 515,607 | 1,010,079 | Neu | +100,0% | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 290,278 | 0 | 290,278 | 978,237 | Neu | +100,0% | |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 634,331 | 0 | 634,331 | 951,498 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 251,300 | 0 | 251,300 | 846,881 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 199,908 | 0 | 199,908 | 673,677 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 199,520 | 0 | 199,520 | 672,382 | Neu | +100,0% | |
| CANADA PENSION PLAN INVESTMENT BOARD | 188,000 | 0 | 188,000 | 633,560 | Neu | +100,0% | |
| Persistent Asset Partners Ltd | 182,046 | 0 | 182,046 | 613,495 | Neu | +100,0% | |
| STATE OF WISCONSIN INVESTMENT BOARD | 180,040 | 0 | 180,040 | 606,735 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-11 | 12.573 | 3,70 | 46.520 |
| 2026-03-02 | 3.176 | 3,42 | 10.862 |
| 2026-02-26 | 1.083 | 3,36 | 3.639 |
| 2026-02-19 | 71 | 4,78 | 339 |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| VANGUARD GROUP INC | 15,958,196 | 53,779,120 | 11.13 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 46,942,000 | 44,735,726 | 9.26 |
| BlackRock, Inc. | 12,784,806 | 43,084,796 | 8.92 |
| Context Capital Management, LLC | 42,119,000 | 39,802,455 | 8.24 |
| UBS Group AG | 11,710,863 | 39,465,609 | 8.17 |
| BANK OF AMERICA CORP /DE/ | 11,521,660 | 38,827,995 | 8.04 |
| RENAISSANCE TECHNOLOGIES LLC | 8,204,973 | 27,650,759 | 5.72 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4,975,939 | 16,768,914 | 3.47 |
| AQR CAPITAL MANAGEMENT LLC | 4,723,531 | 15,918,299 | 3.29 |
| MARSHALL WACE, LLP | 4,424,002 | 14,908,888 | 3.09 |
| STATE STREET CORP | 4,411,222 | 14,865,818 | 3.08 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,623,534 | 12,213,817 | 2.53 |
| D. E. Shaw & Co., Inc. | 11,767,446 | 11,422,518 | 2.36 |
| TWO SIGMA INVESTMENTS, LP | 2,853,205 | 9,615,301 | 1.99 |
| JANE STREET GROUP, LLC | 2,836,462 | 9,558,877 | 1.98 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,759,667 | 9,300,078 | 1.92 |
| Connor, Clark & Lunn Investment Management Ltd. | 1,990,927 | 6,709,424 | 1.39 |
| Qube Research & Technologies Ltd | 1,681,229 | 5,665,742 | 1.17 |
| GOLDMAN SACHS GROUP INC | 1,275,315 | 4,297,812 | 0.89 |
| NORTHERN TRUST CORP | 1,233,685 | 4,157,518 | 0.86 |